Rochester Scientists Present Findings of Alzheimer’s Studies at World’s Largest Dementia Research Forum
Rochester, N.Y.—The Alzheimer’s Association International Conference (AAIC) 2018 brought together more than 5,200 scientists from 65 countries. Members of the Alzheimer’s Association Rochester & Finger Lakes chapter’s med-sci committee Carol Podgorski, Ph.D., and Anton Porteinsson, M.D., were among seven scientists from University of Rochester who presented their research at AAIC. Dr. Podgorski—who is also an honorary board member of the Alzheimer’s Association, Rochester & Finger Lakes Region—presented her study on family therapy in dementia care. Dr. Porteinsson, UR Medicine's Director of AD-Care, reported the results of his team’s S-Citad clinical trial that sought to find an effective combination of non-pharmacologic and pharmacologic approaches to treating agitation in Alzheimer’s disease.
The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.